Delta Pharma, Inc.
FDA 503B outsourcing facility
Ripley, Mississippi
Key Takeaways
- FDA-registered 503B outsourcing facility since 2014
- Sterile compounding from bulk substances: Yes
- Last FDA inspection: November 21, 2025
About this facility
A 503B outsourcing facility is registered with the FDA under the Drug Quality and Security Act and may compound sterile medications in bulk without patient-specific prescriptions, under cGMP manufacturing standards. How federal compounding status works.
FDA registration and inspection record
- First registered with FDA
- August 6, 2014
- Most recent registration
- December 31, 2025
- Compounds sterile drugs from bulk substances
- Yes
- Last FDA inspection
- November 21, 2025
The FDA last inspected Delta Pharma, Inc. on November 21, 2025. Investigators issued a Form FDA 483 listing inspectional observations at that visit. The FDA has not yet determined whether further action will be taken.
What this facility compounds
Delta Pharma, Inc. reports compounding 1 distinct active ingredient to the FDA Outsourcing Facility Product Report (most recent reporting periods).
Tracked on PeptideGrids: Semaglutide.
- Semaglutide
Location
114 W Mulberry St, Ripley, MS 38663
Satellite and street imagery via Esri. Open larger map.
Contact
FDA-registered contact: Stuart Simpson, 662-512-5191. Source: the facility's FDA outsourcing registration.
License verification
503B outsourcing facilities are also licensed by the state board of pharmacy. Verify the current license status of Delta Pharma, Inc. with the Mississippi Board of Pharmacy.
503B facilities in Mississippi
Frequently asked questions
Is Delta Pharma, Inc. registered with the FDA?
Yes. Delta Pharma, Inc. is a registered 503B outsourcing facility, first registered with the FDA on August 6, 2014 and most recently registered on December 31, 2025.
Has Delta Pharma, Inc. been inspected by the FDA?
The FDA last inspected Delta Pharma, Inc. on November 21, 2025. A Form FDA 483 was issued.
Has Delta Pharma, Inc. had any FDA drug recalls?
No FDA drug recalls are matched to Delta Pharma, Inc. in the openFDA enforcement database.
What does Delta Pharma, Inc. compound?
Delta Pharma, Inc. reports compounding 1 active ingredient to the FDA, including Semaglutide.
Where is Delta Pharma, Inc. located?
Delta Pharma, Inc. is located in Ripley, Mississippi (114 W Mulberry St).
Registration and inspection data verified against the FDA list of registered outsourcing facilities on June 6, 2026.
PeptideGrids is independent and not affiliated with, endorsed by, or sponsored by Delta Pharma, Inc.. Listings, registration, inspection, and recall data are reported from public FDA records for informational purposes only. A recall or inspection finding is not an accusation of current wrongdoing. This is not medical or legal advice. To request a correction, see our corrections policy.